ProMetic sales recover on affinity absorbent demand
ProMetic grew third quarter sales on demand for affinity absorbents and expects the recovery to continue.
Archives for November 16, 2011
UCB inks deal with Parexel & PRA to boost cost-effectiveness
UCB has inked a strategic deal with Parexel and PRA that an analyst believes has “very favourable” terms for the biopharm.
Quintiles re-focuses Asia-Pacific commercial services after Invida sale
Quintiles will bring its commercial activities within the Asia-Pacific region in-house after selling its share of jointly established company Invida Group.
IPEC India fees will be ‘fair’ for excipient makers, says IPEC Federation
IPEC India membership dues will be fair for excipient manufacturers, users and distributors in the country according to the IPEC Federation.
Boehringer investing $65m in early development API plant
Boehringer Ingelheim is investing $65m (€48m) in a US API manufacturing facility to meet its early development needs.
Strategic outsourcing coming to EU packaging, United Drug says
United Drug plans to win strategic packaging relationships in Europe as biopharm companies cut fixed costs through outsourcing.
ICH approves revision to preclinical genotoxicity testing guidelines
The ICH has approved a revision to its genotoxicity testing and data interpretation guidelines that it says will improve risk assessment and reduce the number of animals used during preclinical development.
Endeavour creates new intermediates for prion drug developers
Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.